Evexia Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve the quarterly results (Standalone ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Evexia Lifecare has informed BSE that its Board of Directors will meet on Friday, November 14, 2025 to consider and approve the unaudited standalone and consolidated financial results for the quarter ended September 30, 2025 (Q2 FY26). The company also noted that the trading window for insiders, closed ahead of the results, will reopen 48 hours after the results are made public. No financial figures or business details were disclosed in this intimation.
This is a routine regulatory filing and does not impact shareholders on its own. Investors should watch for the actual Q2 results on or after November 14, 2025 for any meaningful business or earnings updates.